DISTRIBUTION OF DYSLIPIDEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ITS CORRELATION WITH PLASMA ATHEROSCLEROSIS INDEX. A CROSS-SECTIONAL STUDY

Santosh Chaudhari, Jingling Wang*, Xiangming Wang and Xuan Li

ABSTRACT

Objective: CKD is defined as abnormalities of kidney structure or function, present for a minimum of 3 months, with implications for health issues in both China and worldwide. CKD is classified based on Cause, Glomerular filtration rate category (G1–G5), and Albuminuria category (A1–A3). Patients with CKD treated with hemodialysis are prone to CVD such as coronary artery atherosclerosis. Dyslipidemia is one of the modifiable risk factors in CKD patients for CVD, incidence is on rise, if left untreated it can result in morbidity and mortality in patients. This cross-sectional study to evaluate the dyslipidemia in chronic kidney disease and normal control groups populations. Methods: From March 2023 to July 2024, 300 chronic kidney diseases with stages 3,4, and 5 were randomly collected, 185 were males and 115 were females and 100 normal control group patients were randomly collected, 81 were female and 19 were males, from the 300 CKD patients 146 are diabetic mellitus and 124 are systemic hypertension, we compare the lipid profiles between both groups who are on hemodialysis and conservative management admitted to affiliated hospital of Shandong second medical university was taken for study purpose. Results: The lipid status of CKD and normal control patients selected overall age of CKD patients was 59.9±13.03 and normal control patients was 53.04±20.42 years with the p value of

Keywords: Dyslipidemia, Chronic kidney disease, Hemodialysis, Lipid profiles, Atherogenic index of plasma.